Global Survey Reveals Suboptimal Molecular Testing Access in Lung Cancer Despite Broad Guidelines - GenomeWeb

Global Survey Reveals Suboptimal Molecular Testing Access in Lung Cancer Despite Broad Guidelines  GenomeWeb

An IASLC survey showed that molecular testing is not performed in line with expert guidelines, which means only a minority of lung cancer patients are ...



Comments

Popular posts from this blog

Lymph node metastasis in cancer progression: molecular mechanisms, clinical significance and therapeutic ...

Stage 4 Lung Cancer Life Expectancy

A Review of the Etiology and Epidemiology of Bladder Cancer: All ...